This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swanson, D. A.
Right arrow Articles by Brody, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swanson, D. A.
Right arrow Articles by Brody, L. C.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2001, p. 1058-1065, Vol. 21, No. 4
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.4.1058-1065.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Targeted Disruption of the Methionine Synthase Gene in Mice

Deborah A. Swanson,1 Mei-Lan Liu,2 Priscilla J. Baker,1 Lisa Garrett,3 Michael Stitzel,1 Jianmin Wu,4 Michelle Harris,2 Ruma Banerjee,4 Barry Shane,2 and Lawrence C. Brody1,*

Genetics and Molecular Biology Branch1 and Genetic Disease Research Branch,3 National Human Genome Research Institute, Bethesda, Maryland 20892; Department of Nutritional Sciences and Toxicology, University of California---Berkeley, Berkeley, California 947202; and Department of Biochemistry, University of Nebraska---Lincoln, Lincoln, Nebraska 685884

Received 2 November 2000/Accepted 10 November 2000

Alterations in homocysteine, methionine, folate, and/or B12 homeostasis have been associated with neural tube defects, cardiovascular disease, and cancer. Methionine synthase, one of only two mammalian enzymes known to require vitamin B12 as a cofactor, lies at the intersection of these metabolic pathways. This enzyme catalyzes the transfer of a methyl group from 5-methyl-tetrahydrofolate to homocysteine, generating tetrahydrofolate and methionine. Human patients with methionine synthase deficiency exhibit homocysteinemia, homocysteinuria, and hypomethioninemia. They suffer from megaloblastic anemia with or without some degree of neural dysfunction and mental retardation. To better study the pathophysiology of methionine synthase deficiency, we utilized gene-targeting technology to inactivate the methionine synthase gene in mice. On average, heterozygous knockout mice from an outbred background have slightly elevated plasma homocysteine and methionine compared to wild-type mice but seem to be otherwise indistinguishable. Homozygous knockout embryos survive through implantation but die soon thereafter. Nutritional supplementation during pregnancy was unable to rescue embryos that were completely deficient in methionine synthase. Whether any human patients with methionine synthase deficiency have a complete absence of enzyme activity is unclear. These results demonstrate the importance of this enzyme for early development in mice and suggest either that methionine synthase-deficient patients have residual methionine synthase activity or that humans have a compensatory mechanism that is absent in mice.


* Corresponding author. Mailing address: Genetics and Molecular Biology Branch, National Human Genome Research Institute, 49 Convent Drive, Rm. 3A14, Bethesda, MD 20892-4442. Phone: (301) 496-7824. Fax: (301) 402-4929. E-mail: lbrody{at}helix.nih.gov.


Molecular and Cellular Biology, February 2001, p. 1058-1065, Vol. 21, No. 4
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.4.1058-1065.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Greene, N. D.E., Stanier, P., Copp, A. J. (2009). Genetics of human neural tube defects. Hum Mol Genet 18: R113-R129 [Abstract] [Full Text]  
  • Dayal, S., Lentz, S. R. (2008). Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes. Arterioscler. Thromb. Vasc. Bio. 28: 1596-1605 [Abstract] [Full Text]  
  • Kullo, I. J., Ding, K., Boerwinkle, E., Turner, S. T., Mosley, T. H. Jr, Kardia, S. L.R., de Andrade, M. (2006). Novel Genomic Loci Influencing Plasma Homocysteine Levels. Stroke 37: 1703-1709 [Abstract] [Full Text]  
  • Devlin, A. M., Lentz, S. R. (2006). ApoA-I: A Missing Link Between Homocysteine and Lipid Metabolism?. Circ. Res. 98: 431-433 [Full Text]  
  • Oltean, S., Banerjee, R. (2005). A B12-responsive Internal Ribosome Entry Site (IRES) Element in Human Methionine Synthase. J. Biol. Chem. 280: 32662-32668 [Abstract] [Full Text]  
  • Dayal, S., Devlin, A. M., McCaw, R. B., Liu, M.-L., Arning, E., Bottiglieri, T., Shane, B., Faraci, F. M., Lentz, S. R. (2005). Cerebral Vascular Dysfunction in Methionine Synthase-Deficient Mice. Circulation 112: 737-744 [Abstract] [Full Text]  
  • Dayal, S., Lentz, S. R (2005). ADMA and hyperhomocysteinemia. Vasc Med 10: S27-S33 [Abstract]  
  • Dayal, S., Lentz, S. R (2005). ADMA and hyperhomocysteinemia. Vasc Med 10: S27-S33 [Abstract]  
  • Zhang, W., Braun, A., Bauman, Z., Olteanu, H., Madzelan, P., Banerjee, R. (2005). Expression Profiling of Homocysteine Junction Enzymes in the NCI60 Panel of Human Cancer Cell Lines. Cancer Res. 65: 1554-1560 [Abstract] [Full Text]  
  • Olteanu, H., Banerjee, R. (2003). Redundancy in the Pathway for Redox Regulation of Mammalian Methionine Synthase: REDUCTIVE ACTIVATION BY THE DUAL FLAVOPROTEIN, NOVEL REDUCTASE 1. J. Biol. Chem. 278: 38310-38314 [Abstract] [Full Text]  
  • Oltean, S., Banerjee, R. (2003). Nutritional Modulation of Gene Expression and Homocysteine Utilization by Vitamin B12. J. Biol. Chem. 278: 20778-20784 [Abstract] [Full Text]  
  • Di Pietro, E., Sirois, J., Tremblay, M. L., MacKenzie, R. E. (2002). Mitochondrial NAD-Dependent Methylenetetrahydrofolate Dehydrogenase-Methenyltetrahydrofolate Cyclohydrolase Is Essential for Embryonic Development. Mol. Cell. Biol. 22: 4158-4166 [Abstract] [Full Text]  
  • Olteanu, H., Banerjee, R. (2001). Human Methionine Synthase Reductase, a Soluble P-450 Reductase-like Dual Flavoprotein, Is Sufficient for NADPH-dependent Methionine Synthase Activation. J. Biol. Chem. 276: 35558-35563 [Abstract] [Full Text]